Invention Grant
US09073963B2 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
有权
肽和肽模拟物可用于抑制前列腺素F2α受体的活性
- Patent Title: Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
- Patent Title (中): 肽和肽模拟物可用于抑制前列腺素F2α受体的活性
-
Application No.: US12423975Application Date: 2009-04-15
-
Publication No.: US09073963B2Publication Date: 2015-07-07
- Inventor: Krishna Peri , Felix Polyak , William Lubell , Eryk Thouin , Sylvain Chemtob
- Applicant: Krishna Peri , Felix Polyak , William Lubell , Eryk Thouin , Sylvain Chemtob
- Applicant Address: CA Montreal CA Saint Laurent
- Assignee: Universite De Montreal,Theratechnologies, Inc.
- Current Assignee: Universite De Montreal,Theratechnologies, Inc.
- Current Assignee Address: CA Montreal CA Saint Laurent
- Agency: Gottlieb, Rackman & Reisman, P.C.
- Priority: WOPCT/CA03/000903 20030611
- Main IPC: C07K7/06
- IPC: C07K7/06 ; A61K38/00
Abstract:
The invention relates to compositions which are useful for inhibiting prostaglandin F2α receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
Public/Granted literature
- US20120172318A1 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR Public/Granted day:2012-07-05
Information query
